Global Rank
#47112
Country Rank
n/a
Market Cap
1.25 M
Price
0.39
Change (%)
2.00%
Volume
157
Cronex.Co.,Ltd's latest marketcap:
1.25 M
As of 06/07/2025, Cronex.Co.,Ltd's market capitalization has reached $1.25 M. According to our data, Cronex.Co.,Ltd is the 47112th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.25 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 0 |
| Shares Out | 3.19 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Market Cap Chart
Data Updated: 06/07/2025
Cronex.Co.,Ltd's yearly market capitalization.
Cronex.Co.,Ltd has seen its market value drop from ₩18.2 B to ₩1.72 B since 2020, representing a total decrease of 90.56% and an annual compound decline rate (CAGR) of 41.26%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/07/2025 | ₩1.72 B | -8.64% |
| 12/30/2024 | ₩1.88 B | -37.83% |
| 12/28/2023 | ₩3.02 B | -54.7% |
| 12/29/2022 | ₩6.68 B | -57.85% |
| 12/30/2021 | ₩15.84 B | -12.96% |
| 12/30/2020 | ₩18.2 B |
Company Profile
About Cronex Co., Ltd.
Cronex Co., Ltd. specializes in the research and development of medicines and raw materials for medical applications. Established in 2012 and headquartered in Seoul, South Korea, the company provides a range of innovative services in the medical and pharmaceutical fields.
Core Services
- Contract Research Organization (CRO) Services: Includes dental materials, implant materials, bone marrow restoration, bone regeneration, skin penetration studies, and high-frequency therapy device testing.
- Efficacy Evaluations: Conducts tests for spinal implants, bone graft materials, cartilage regeneration, X-ray, micro-CT, and histology.
- Preclinical Drug Development: Performs drug effectiveness evaluations using minipigs, beagle dogs, and rabbits.
- Animal Testing & Management: Offers test progress tracking, animal anesthesia, post-test care, sampling, and comprehensive evaluations.
Additional Offerings
- Medical Collagens & Disease Testing: Provides high-quality collagens and diagnostic testing services.
- Transgenic Pig Model Research: Utilizes gene editing and somatic cell nuclear transfer technology for advanced medical research.
Frequently Asked Questions
-
What is Cronex.Co.,Ltd's (XKON-215570) current market cap?As of 06/07/2025, Cronex.Co.,Ltd (including the parent company, if applicable) has an estimated market capitalization of $1.25 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Cronex.Co.,Ltd (XKON-215570) rank globally by market cap?Cronex.Co.,Ltd global market capitalization ranking is approximately 47112 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.